We review our recent optical experiments on two-dimensional electron systems at temperatures below 1 K and under high magnetic fields. The two-dimensional electron systems are realized in modulation-doped GaAs-AlGaAs single quantum wells. Via gate electrodes the carrier density of the two-dimensional electron systems can be tuned in a quite broad range between about 1×10^{10} cm^{-2} and 2×10^{11} cm^{-2}. In dilute two-dimensional electron systems, at very low electron densities, we observe the formation of negatively charged excitons in photoluminescence experiments. In this contribution we report about the observation of a dark triplet exciton, which is observable at temperatures below 1 K and for electron filling factors <1/3, i.e., in the fractional quantum Hall regime only. In experiments where we have increased the density of the two-dimensional electron systems so that a uniform two-dimensional electron system starts to form, we have found a strong energy anomaly of the charged excitons in the vicinity of filling factor 1/3. This anomaly was found to exist in a very narrow parameter range of the density and temperature, only. We propose a model where we assume that localized charged excitons and a uniform Laughlin liquid coexist. The localized charged exciton in close proximity to the Laughlin liquid leads to the creation of a fractionally-charged quasihole in the liquid, which can account for the experimentally observed anomaly.
Surfactant proteins A (SP-A) and D (SP-D) are lung surfactant-associated hydrophilic proteins which have been implicated in surfactant homeostasis and pulmonary innate immunity. They are collagen-containing C-type (calcium-dependent) lectins, called collectins, and are structurally similar to mannose-binding protein of the lectin pathway of the complement system. Being carbohydrate pattern-recognition molecules, they recognize a broad spectrum of pathogens and allergens via the lectin domain, with subsequent activation of immune cells via the collagen region, thus offering protection against infection and allergenic challenge. SP-A and SP-D have been shown to be involved in viral neutralization, clearance of bacteria, fungi, and apoptotic and necrotic cells, the down-regulation of allergic reaction, and the resolution of inflammation. Studies on single-nucleotide polymorphism, protein levels in broncho-alveolar lavage, and gene knock-out mice have clearly indicated an association between SP-A and SP-D and a range of pulmonary diseases. In addition, recent studies using murine models of allergy and infection have raised the possibility that the recombinant forms of SP-A and SP-D may have therapeutic potential in controlling pulmonary infection, inflammation, and allergies in humans.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.